logo
Plus   Neg
Share
Email

FDA Approves Amgen's Osteoporosis Drug Evenity

The U.S. Food and Drug Administration Tuesday approved Amgen Inc.'s (AMGN) Evenity for treatment of osteoporosis in postmenopausal women, who are at high risk of bone fractures.

More than 10 million people in the U.S. have osteoporosis, which is most common in women who have gone through menopause. People with osteoporosis have weakened bones that are more likely to fracture.

"Today's approval provides women with postmenopausal osteoporosis who are at high risk of fracture with a new treatment that will reduce this risk," said Hylton Joffe, director of the Center for Drug Evaluation and Research's Division of Bone, Reproductive and Urologic Products.

However, Evenity increases the risk of cardiovascular death, heart attack and stroke in the alendronate trial, but not in the placebo trial. Evenity contains a boxed warning on its labeling stating that it may increase the risk of heart attack, stroke and cardiovascular death and should not be used in patients who have had a heart attack or stroke within the previous year.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The United Auto Workers union reportedly plans to go on strike against auto giant General Motors Co. (GM) after both the parties failed to reach a tentative deal before a Saturday deadline. According to CNBC, the strike has been called despite GM saying it presented a "strong offer" to the union.... Millennials and Generation Zs, or people aged between 18 to 34 year, pay more for car repairs, according to a new survey. The average American spent $1,986 over the past five years on vehicle repairs and maintenance, according to a survey by Ally Financial conducted by Harris Poll. However, among... Gap Inc.'s (GPS) Old Navy brand announced plans to open 800 new stores as part of its upcoming split from its parent company. "We'll almost double our fleet to 2,000 stores in North America, predominantly in under-served small markets," Old Navy CEO Sonia Syngal said. The company said the plan was...
Follow RTT